Prognostic effects of microcirculation-assisted adjustment of venoarterial blood flow in extracorporeal membrane oxygenation: A prospective, pilot, randomized controlled trial

医学 微循环 体外膜肺氧合 血流 前瞻性队列研究 体外 随机对照试验 充氧 临床试验 内科学 心脏病学 麻醉 外科
作者
Ping-Ju Chen,Yu‐Chang Yeh,Chi-Hsiang Huang,Tzu-Jung Wei,Chun‐Fu Lai,Yun-Ping Yang,Yih‐Sharng Chen,Chih-Hsien Wang,Chen-Tse Lee
出处
期刊:Asian Journal of Surgery [Elsevier BV]
卷期号:46 (9): 3549-3554 被引量:1
标识
DOI:10.1016/j.asjsur.2023.03.069
摘要

OBJECTIVE: The study explored the clinical efficacy of microcirculation-assisted blood flow adjustment in patients receiving venoarterial extracorporeal membrane oxygenation (VA-ECMO). METHODS: This prospective, pilot, randomized controlled trial was conducted from 2018 to 2021; enrolled patients were randomly assigned to the microcirculation or control group at a 1:1 ratio. Microcirculatory and clinical data were collected within 24 h (T1) and at 24-48 h (T2), 48-72 h (T3), and 72-96 h (T4) after ECMO initiation and were compared between the groups following the intention-to-treat (ITT) principle. The primary outcome was the Sequential Organ Failure Assessment (SOFA) score at T2. In addition to ITT analysis, analysis based on the as-treated (AT) principle was performed. RESULTS: A total of 35 patients were enrolled in this study. At T2, the SOFA score did not significantly differ between the microcirculation and control groups (16 [14.8-17] vs. 16 [12.5-18], P = 0.782). Generalized estimating equation analysis demonstrated a significantly greater reduction in the SOFA score over time in the microcirculation-AT group than in the control-AT group (estimated difference: -0.767, standard error: 0.327, P = 0.019). The lactate level at T2 was significantly lower in the microcirculation-AT group (2.7 [2.0-3.6] vs. 4.1 [3.0-6.6] mmol/L, P = 0.029). No significant difference in the 30-day survival rate was noted between the groups. CONCLUSION: This prospective pilot study demonstrated the feasibility of microcirculation-assisted VA-ECMO blood flow adjustment despite no significant clinical benefit for critically ill patients. More efforts in personnel training and newer technologies may help achieve microcirculation optimization.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage的应助被朴素的士晋采纳,获得10
刚刚
molihuakai的应助被阳光雨堂采纳,获得10
刚刚
搞怪的芙发布了新的文献求助10
1秒前
慕青的应助被YH采纳,获得10
1秒前
yu完成签到,获得积分20
2秒前
2秒前
星辰大海的应助被WYL采纳,获得10
2秒前
3秒前
哈基米完成签到,获得积分10
3秒前
3秒前
4秒前
Hasson发布了新的文献求助10
4秒前
十一完成签到,获得积分10
4秒前
4秒前
drugster完成签到,获得积分10
4秒前
SciGPT的应助被heoouijee采纳,获得10
4秒前
112233完成签到,获得积分10
5秒前
桐桐的应助被香橙采纳,获得10
5秒前
所所的应助被流年采纳,获得10
5秒前
852的应助被务实的书芹采纳,获得10
5秒前
6秒前
CarryLJR发布了新的文献求助10
6秒前
研友_VZG7GZ的应助被flamez采纳,获得10
6秒前
天天快乐的应助被靓丽芙蓉采纳,获得10
6秒前
7秒前
7秒前
7秒前
zzzzz完成签到,获得积分10
7秒前
xgx984完成签到,获得积分10
7秒前
一杯芝士发布了新的文献求助10
7秒前
7秒前
Zero发布了新的文献求助10
7秒前
哈基米发布了新的文献求助10
7秒前
sss的应助被drizzle采纳,获得10
8秒前
专一的飞莲完成签到,获得积分10
8秒前
criz1完成签到,获得积分10
8秒前
8秒前
Vearseap完成签到,获得积分10
9秒前
一二三完成签到,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417